BVT Aktienanleihe MRK 28.06.2024/ DE000VM0BT10 /
2024-05-15 10:31:10 AM | Chg.+0.670 | Bid12:18:43 PM | Ask12:18:43 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
99.950EUR | +0.67% | 99.860 Bid Size: 500,000 |
100.360 Ask Size: 500,000 |
MERCK KGAA O.N. | 162.55 EUR | 2024-06-28 | Call |
GlobeNewswire
05-14
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA